Literature DB >> 8441751

Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.

R P Kosman1, J E Gouaux, W N Lipscomb.   

Abstract

The X-ray crystal structure of CTP-ligated T state aspartate transcarbamoylase has been refined to an R factor of 0.182 at 2.5 A resolution using the computer program X-PLOR. The structure contains 81 sites for solvent and has rms deviations from ideality in bond lengths and bond angles of 0.018 A and 3.722 degrees, respectively. The cytosine base of CTP interacts with the main chain carbonyl oxygens of rTyr-89 and rIle-12, the main chain NH of rIle-12, and the amino group of rLys-60. The ribose hydroxyls form polar contacts with the amino group of rLys-60, a carboxylate oxygen of rAsp-19, and the main chain carbonyl oxygen of rVal-9. The phosphate oxygens of CTP interact with the amino group of rLys-94, the hydroxyl of rThr-82, and an imidazole nitrogen of rHis-20. Recent mutagenesis experiments evaluated in parallel with the structure reported here indicate that alterations in the hydrogen bonding environment of the side chain of rAsn-111 may be responsible for the homotropic behavior of the pAR5 mutant of ATCase. The location of the first seven residues of the regulatory chain has been identified for the first time in a refined ATCase crystal structure, and the proximity of this portion of the regulatory chain to the allosteric site suggests a potential role for these residues in nucleotide binding to the enzyme. Finally, a series of amino acid side chain rearrangements leading from the R1 CTP allosteric to the R6 CTP allosteric site has been identified which may constitute the molecular mechanism of distinct CTP binding sites on ATCase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8441751     DOI: 10.1002/prot.340150206

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  15 in total

1.  Structural basis for ordered substrate binding and cooperativity in aspartate transcarbamoylase.

Authors:  Jie Wang; Kimberly A Stieglitz; James P Cardia; Evan R Kantrowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

2.  Aspartate transcarbamylase from the deep-sea hyperthermophilic archaeon Pyrococcus abyssi: genetic organization, structure, and expression in Escherichia coli.

Authors:  C Purcarea; G Hervé; M M Ladjimi; R Cunin
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

Review 3.  Structure and mechanisms of Escherichia coli aspartate transcarbamoylase.

Authors:  William N Lipscomb; Evan R Kantrowitz
Journal:  Acc Chem Res       Date:  2011-10-19       Impact factor: 22.384

4.  The pathway of product release from the R state of aspartate transcarbamoylase.

Authors:  Kimberly R Mendes; Evan R Kantrowitz
Journal:  J Mol Biol       Date:  2010-07-08       Impact factor: 5.469

5.  The use of nucleotide analogs to evaluate the mechanism of the heterotropic response of Escherichia coli aspartate transcarbamoylase.

Authors:  J B Sakash; A Tsen; E R Kantrowitz
Journal:  Protein Sci       Date:  2000-01       Impact factor: 6.725

6.  A cooperative Escherichia coli aspartate transcarbamoylase without regulatory subunits .

Authors:  Kimberly R Mendes; Evan R Kantrowitz
Journal:  Biochemistry       Date:  2010-09-07       Impact factor: 3.162

7.  Weakening of the interface between adjacent catalytic chains promotes domain closure in Escherichia coli aspartate transcarbamoylase.

Authors:  D P Baker; L Fetler; R T Keiser; P Vachette; E R Kantrowitz
Journal:  Protein Sci       Date:  1995-02       Impact factor: 6.725

8.  Metal ion involvement in the allosteric mechanism of Escherichia coli aspartate transcarbamoylase.

Authors:  Gregory M Cockrell; Evan R Kantrowitz
Journal:  Biochemistry       Date:  2012-08-24       Impact factor: 3.162

9.  Submicromolar phosphinic inhibitors of Escherichia coli aspartate transcarbamoylase.

Authors:  Laëtitia Coudray; Evan R Kantrowitz; Jean-Luc Montchamp
Journal:  Bioorg Med Chem Lett       Date:  2008-12-06       Impact factor: 2.823

10.  The molecular basis of ornithine transcarbamylase deficiency: modelling the human enzyme and the effects of mutations.

Authors:  M Tuchman; H Morizono; O Reish; X Yuan; N M Allewell
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.